catalyst

Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizop — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2018-06 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizop — primary completion
Type
Trial Readout
Date
2018-06
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
trial